SURUNKALI GEPATITDA BIOKIMYOVIY TESTLARNING JIGAR FIBROZINING OG‘IRLIGI BILAN BOG‘LIQLIGINI O‘RGANISH
Keywords:
Kalit so’zlar: surunkali gepatit, yog’li jigar gepatozi, alkogol, diagnostika.Abstract
Annotatsiya: Ushbu maqolada jigar fibrozining qon zardobidagi markerlari: α2-makroglobulin va apolipoprotein A1 alkogolli gepatit va alkogolsiz yog‘li jigar gepatozi bilan og‘rigan bemorlarda jigar zichligi bilan o‘rtasida kuchli ijobiy munosabatlari ko‘rsatilgan.
References
Adabiyotlar:
1. Ахмедов, Т.Ж., Ешмуратов, Б.А., & Бахриев, И.И. (2023). Аффин хроматография усулида А антигенининг гурухчаларини аниклаш.
2. Бахриев, И.И., & Джалалов, Д.Д. (2001). Қон, сперма ва сочларни суд тиббиётига оид текшириш. Талабалар учун услубий қўлланма.
3. Lochinov, F. N., & Baxriyev, I. I. (2022). Biologik tabiatga ega bo‘lgan ashyoviy dalillarning Sud-Tibbiy Ekspertizasi.
4. Чориев, Б. А., & Бахриев, И. И. (2023). Далилий ашёларни суд-биологик экспертизадан утказишда классик тадқиқот усулларининг аҳамияти.
5. Bueverov A.O., Mayevskaya M.V., Ivashkin V.T. Alkogolli jigar kasalliklarini davolashda differentsial yondashuv. 2005. - № 5. - B. 5-9.
6. Butorova L.I. Semirib ketishda alkogolsiz yog‘li jigar kasalligining tarqalishi va uning yurak-qon tomir kasalliklari va 2-tip diabet uchun xavf omillari bilan bog‘liqligi. //Shifokorlar uchun qo‘llanma. - M.: Forte nashri. 2012.
7. Nikitin I.G. Alkogolsiz yog‘li jigar kasalligining tarqalishini aniqlash va kasallikning rivojlanishi uchun xavf omillarini aniqlash bo‘yicha skrining dasturi 2010. - №1. - V. 41-46.
8. Xazanov A.I. Statsionar bemorlarda jigar sirrozi etiologiyasini uzoq muddatli o‘rganish natijalari (1946-2005). 2006. - №2. - V. 11-18.
6. Xlinova O.V., Kats M.B., Zubareva V.D., Yamaltdinova L.A. Tashxis qo‘yishning qiyin yo‘li: Klatskin o‘smasi (klinik kuzatuv) //Gastroenterologiya, Gepatologiyaning klinik istiqbollari. 2011. - №1. - V. 25-29.
9. Dyson J.K., McPherson S., Anstee Q.M. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification //J. Clin. Pathol. 2013. - №12. - R. 1033-1045.
10. EASL Clinical Practice Guidelines: management of hepatitis C virus infection //J. Hepatol. 2011. - №2. - R. 245-264.
11. Hasegawa T., Murata C., Ninomiya T. et al. Occupational Factors and Problem Drinking among a Japanese Working Population //Ind. Health. 2013. - №5. - P. 490-500.
12. Kim W.R., Brown R.S. Jr. Burden of liver disease in the United States: summary of a workshop //Hepatology. 2002. - №1. P. 227-242.
13. Mathurin P., Vidaud D., Vidaud M. et al. Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease //Hepatology. 1996. - № 1. P. 44-51.
14. Michitaka K., Nishiguchi S., Aoyagi Y. et al. Japan Etiology of Liver Cirrhosis Study Group. Etiology of liver cirrhosis in Japan: a nationwide survey //J. Gastroenterol. 2010. - № 1. P. 86-94.
15. Naveau S., Thaury J., Barri-Ova N. et al. Predictive factors for pure steatosis in alcoholic patients //Alcohol. Clin. Exp. Res. 2009. - №6. P. 1104-1110.
16. Rosmorduc O. Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: which clinical arguments? //Ann. Endocrinol. (Paris). 2013. - №2. P. 115-120.
17. Samuel C.E. Antiviral actions of interferons //Clin. Microbiol. Rev. 2001. - №4. - P. 778-809.
18. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults //Aliment. Pharmacol. Ther. 2011. - №3. - P. 274-285.
